BCYC
Bicycle Therapeutics plc · Healthcare
Chief Scientific Officer Nicholas Keen sold $53K of Bicycle Therapeutics plc
Sold$52,802
$29.06Price
1,817Shares
−4%Stake
What BCYC did after the filing
- The stock from Fri, Jan 6 open, $30.88
- −21.8%
- S&P 500, same days
- +4.3%
Measured over 30 trading days, to the Feb 21 close.
Traded Tue, Jan 3. Filed Thu, Jan 5, 4:14 PM ET, after the close. Returns use the Jan 6 open and the Feb 21 close. Not investment advice.